Supplement Label Index / Cardiovascular Research

Nialipin 400 mg

Cardiovascular Research · Tablet or Pill · Off market

Matched compounds

Compound	Form	Tier	Amount
Niacin (Vitamin B3)	Niacin (Nicotinic Acid)	Tier 1	400 mg

How these doses compare

Niacin (Vitamin B3): 400 mg NE per serving — higher than 96% of 11,982 on-market products declaring it (market median 20 mg NE).

Per serving as declared; serving sizes and daily directions differ between products.

Excipients

Ethylcellulose
Glaze (unspecified)
Hypromellose
Microcrystalline Cellulose
Silicon Dioxide — Food Additive Index
Stearic Acid

Label statements

identity: Dietary Supplement
other: Nialipin is well-tolerated by sensitive individuals.
other: Hypersensitive individuals are advised to start with one tablet prior to increasing dosage. Each sustained-release tablet is designed to release niacin over a period of 6 to 8 hours. Do not cut tablets in half.
other: Directions Take or or two tablets daily, or as directed by a physician.
warning: Do not take niacin unless recommended by and taken under the supervision of a physician if you have any of the following conditions: gallbladder disease, gout, arterial bleeding, glaucoma, diabetes, impaired liver function, peptic ulcer, or if you are pregnant or lactating.
claim: Ecological Formulas
other: Sustained-release niacin
other: Gluten free, casein free
other: This product has not been evaluated by the FDA. This product is not intended to diagnose, cure, treat or prevent any disease.

View original label on DSLD → · Add to the Stack Checker

Label facts as declared by the manufacturer to the NIH Dietary Supplement Label Database (DSLD), not independently lab-tested. This page reports what the label says; it does not rate, score, or recommend this product.